Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2010
10/06/2010CN101129362B Sirolimus dispersible tablets and method of producing the same
10/06/2010CN101108172B Oral sticking tablet and method of preparing the same
10/06/2010CN101095670B Luteolin phospholipid complexes and method for preparing the same and application thereof
10/06/2010CN101095666B Novel hydrochloric acid tramadol sustained-release tablet and preparation method
10/06/2010CN101081213B Butane diacid(5-androstene-17-ketone- 3beta -hydroxyl group ) diester solid dispersoid and method for making same and applications thereof
10/06/2010CN101039660B Stable pegylated interferon formulation
10/06/2010CN101011393B Irbesartan gastric retention sustained-release pharmaceutical composition
10/05/2010US7809428 Devices for detection and therapy of atheromatous plaque
10/05/2010US7807824 in which reducing terminal unit is transformed into aldehyde group, hydroxylation; drug delivery
10/05/2010US7807782 Using targeted reactions between proline and adapter segments as tool in generation of preferential fusion proteins; directed protein evolution
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807722 Biobeneficial coating compositions and methods of making and using thereof
10/05/2010US7807680 Controlled release sterile injectable aripiprazole formulation and method
10/05/2010US7807675 Hyaluronic acid-methotrexate conjugate
10/05/2010US7807202 Mixture of tea tree oil and mineral such as selenium, iodine or silver; warts caused by the Molluscum contagiosum virus, human papillomavirus, and/or herpes simplex virus, chicken pox or shingles; does not destroy healthy, uninfected tissues, side effect reduction
10/05/2010US7807198 containing a polymer, a therapeutic agent, and a complexing agent, where the polymer interacts with the complexing agent in a host-guest or a guest-host interaction to form an inclusion complex; may be used to deliver a therapeutic agent in treatment of various disorders
10/05/2010US7807194 Plasticizer, film former, bulking agent, and pH controlling agent;
10/05/2010US7807185 applying to skin or mucous membrane of a mammal a composition comprising an extracellular product of a Pseudomonas lindbergii strain, an extracellular product of a Bacillus coagulans strain, and an anti-fungal agent selected from Amphotericin B, Carbol-Fuchsin, Ciclopirox, for example
10/05/2010US7807179 Reoviridae virus is conjugated to a hydroxylated hydrocarbon or a polycationic polymer to reduce the clearance and immunogenicity; antiproliferative disorders
10/05/2010US7807169 Stratified and cryogenically stored vaccines, process for their preparation
10/05/2010US7807151 identifying a mammalian subject having an infection with said pathogenic Clostridium bacterium resistant to antibiotic, orally administering a therapeutically-effective concentration of Bacillus coagulans bacteria
10/05/2010US7807144 Immunization of aquatic animals such as fish and shrimp against infectious diseases; drug delivery using a transfected bioencapsulated organism such as Artemia, rotifer, alga, or paramecium as food for a fish
10/05/2010US7807142 comprising interleukin-2 (IL-2); using an amino acid base sufficient to decrease aggregate formation of the polypeptide during storage of the composition, and a buffering agent ; mixture with amino acid and buffer
10/05/2010US7807134 BBN[7-13] peptide as targeting molecule, paclitaxel as therapeutic agent, a polyethylene glycol linker, a lysine or diamino benzoic acid core molecule, biotin as scaffold binding element and streptavidin as the scaffold moiety; anticarcinogenic agents; improved pharmacokinetics; intraveinous injection
10/05/2010US7807133 Diagnosis, therapy of tumors; as compared to avidin, the diavidins have shown ability to increase amount of labelled biotin on target, when used in an in vitro pretargeting test using supported human tenascin, the biotinylated anti-tenascin monoclonal antibody (Mab-B), avidin/diavidin, and biotin-3H
10/05/2010CA2473450C Multifunctional particulate material, fluid, and composition
10/05/2010CA2455167C New pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
10/05/2010CA2452638C Optimised formulation of tobramycin for aerosolization
10/05/2010CA2431705C Method for preparing submicron particle suspensions
10/05/2010CA2425218C Pharmaceutical solutions of modafinil compounds
10/05/2010CA2393297C Polyhydroxystilbenes as antipsoriatic agents and protein kinase inhibitors
10/05/2010CA2370784C Endodontic fibers and methods of use therefor
10/05/2010CA2369595C Conjugate having a cleavable linkage for use in a liposome
10/05/2010CA2361951C Process for producing a powder containing crystalline particles of maltitol
10/05/2010CA2331744C Aloe pectins
10/05/2010CA2322516C Sustained release macrolide compositions
09/2010
09/30/2010WO2010111680A2 Dry powder formulations and methods for treating pulmonary diseases
09/30/2010WO2010111650A2 Calcium citrate and calcium lactate formulations for alteration of biophysical properties of mucosal lining
09/30/2010WO2010111644A1 Pharmaceutical formulations and methods for treating respiratory tract infections
09/30/2010WO2010111640A2 Anti-influenza formulations and methods
09/30/2010WO2010111533A2 Transdermal delivery of pkc modulatory peptides through microporated skin
09/30/2010WO2010111449A1 Intraocular sustained release drug delivery systems and methods for treating ocular conditions
09/30/2010WO2010111264A2 Rasagiline formulations
09/30/2010WO2010111221A2 Compositions and methods for preferential distribution of active agents to injury sites
09/30/2010WO2010111215A2 Compositions and methods for treatment of hemorrhage
09/30/2010WO2010111212A1 Methods of identifying potential components for targeted drug delivery compositions
09/30/2010WO2010111198A1 Compounds compositions and methods of treating cancer and fibrotic diseases
09/30/2010WO2010111178A2 Drug depots for treatment of pain and inflammation in sinus and nasal cavities or cardiac tissue
09/30/2010WO2010111115A1 Method for preparing suspensions of low-solubility materials
09/30/2010WO2010110916A2 Determination of tracers within subjects
09/30/2010WO2010110760A1 Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
09/30/2010WO2010110518A1 Antifungal composition
09/30/2010WO2010110471A1 Lipid membrane structure
09/30/2010WO2010110455A1 Polyion complex comprising hydrophobized polyamino acid and use of same
09/30/2010WO2010110436A1 Matrix-type sustained release preparation containing basic additive
09/30/2010WO2010110334A1 Readily water-soluble myricitrin composition
09/30/2010WO2010110328A1 Readily water-soluble isoquercitrin composition
09/30/2010WO2010110322A1 Solid preparation
09/30/2010WO2010110321A1 Adhesion preventing composition, solid preparation and method for producing same
09/30/2010WO2010110318A1 Therapeutic agent for arteriosclerotic diseases comprising nucleic acid
09/30/2010WO2010110314A1 Therapeutic agent for pulmonary hypertension comprising nucleic acid
09/30/2010WO2010110220A1 Dispersion and manufacturing method therefor
09/30/2010WO2010110018A1 Coated solid preparation
09/30/2010WO2010109961A1 Burdock fruit extract containing arctigenin at high content and process for producing same
09/30/2010WO2010109913A1 Transdermal preparation
09/30/2010WO2010109544A1 Composition for external application containing nucleic acid as active ingredient
09/30/2010WO2010109475A1 A sustained release oral composition of an antipsychotic agent
09/30/2010WO2010109434A2 A medicinal antibacterial, antifungal and steroids cream and a process to make it
09/30/2010WO2010109433A1 An antiviral medicinal cream and a process to make it
09/30/2010WO2010109432A1 An antiscabies medicinal cream and a process to make it
09/30/2010WO2010109425A2 A medicinal steroids cream and a process to make it
09/30/2010WO2010109424A1 A medicinal antibacterial and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109423A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109422A1 A medicinal cream for diaper rash and a process to make it
09/30/2010WO2010109421A1 A medicinal antifungal and steroids cream comprising chitosan and a process to make it
09/30/2010WO2010109420A1 A medicinal anti acne cream comprising chitosan and a process to make it
09/30/2010WO2010109418A1 A medicinal antifungal cream and a process to make it
09/30/2010WO2010109417A1 A medicinal antibacterial cream and a process to make it
09/30/2010WO2010109212A2 Carrier
09/30/2010WO2010108937A2 Drug fusions and conjugates
09/30/2010WO2010108683A1 Use of date syrup as a binder
09/30/2010WO2010108494A1 Dayspepsia treatment with alginate
09/30/2010WO2010108493A1 A stable iron oligosaccharide compound
09/30/2010WO2010108314A1 Use of fiber pentose or composition containing fiber pentose in manufacture of foods or medicines for preventing and/or treating acidification in diabetic patient
09/30/2010WO2010093285A8 Composition comprising biodegradable carrier for controlled drug delivery
09/30/2010WO2010071320A3 Controlled-release composition for producing sustained-release preparation containing udenafil
09/30/2010WO2009108554A3 System for delivery of protein in insoluble fibrillar or aggregate form
09/30/2010US20100249794 Composite Bone Graft Substitute Cement and Articles Produced Therefrom
09/30/2010US20100249250 Reversible biogel for manipulation and separation of single-walled carbon nanotubes
09/30/2010US20100249249 Reduction of the Formation of Biofilm by Means of Multifunctional Copolymers
09/30/2010US20100249240 Synergistic mixed poloxamer systems for the solubilisation of drugs
09/30/2010US20100249218 Method to inhibit cell growth using oligonucleotides
09/30/2010US20100249072 Prodrugs and conjugates of prenylation inhibitors
09/30/2010US20100249039 Methods for Treating Cancer Using an Immunotoxin
09/30/2010US20100248334 Biological active coating components, coatings, and coated surfaces
09/30/2010US20100247689 Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue
09/30/2010US20100247676 Compositions and methods for treatment of hemorrhage
09/30/2010US20100247668 Polymer-agent conjugates, particles, compositions, and related methods of use
09/30/2010US20100247666 Method for Preparing Suspensions of Low-Solubility Materials
1 ... 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 ... 1712